Concord Biotech Limited
Paresh Patel currently serves as the Manager of Engineering and Project at Concord Biotech Limited since January 2019. Prior to this role, Paresh Patel gained extensive experience as a Senior Engineer at Dishman Pharmaceutical & Chemical Ltd from August 2006 to April 2023. This professional background reflects a strong commitment to engineering and project management within the pharmaceutical and biotechnology sectors.
Concord Biotech Limited
Concord Biotech Limited is an R&D based Biotechnology company, having focus on the fermentation, semi-synthetic and synthesis based products. Since its inception in 2000, Concord has recorded an excellent growth through diversification and process improvements. Having state-of-the-art US FDA & EUGMP approved facility; Concord is a professionally managed globally recognised supplier of fermentation based API’s and enzyme & offers services in biotechnology area like strain improvement & contract fermentation/ manufacturing. The existing portfolio of products includes API’s in the immunosuppressant, antibiotic, Oncology , Anti-Obesity, hypolipemic segments and enzymes. However, with the expertise in the field of biotechnology and chemistry, the R&D team at Concord is working towards adding new products to the product basket.